Bartlett & Co’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$5K Sell
317
-1,863
-85% -$25.3K ﹤0.01% 1076
2023
Q3
$38K Sell
2,180
-134
-6% -$2.79K ﹤0.01% 710
2023
Q2
$48K Sell
2,314
-96
-4% -$2.09K ﹤0.01% 679
2023
Q1
$57K Sell
2,410
-241
-9% -$6.47K ﹤0.01% 551
2022
Q4
$74K Sell
2,651
-157
-6% -$4.01K ﹤0.01% 515
2022
Q3
$66K Sell
2,808
-580
-17% -$17.5K ﹤0.01% 523
2022
Q2
$114K Sell
3,388
-8
-0.2% -$280 ﹤0.01% 444
2022
Q1
$119K Buy
+3,396
New +$116K ﹤0.01% 456
2021
Q4
Sell
-3,840
Closed -$126K 726
2021
Q3
$126K Sell
3,840
-4,242
-52% -$136K ﹤0.01% 384
2021
Q2
$245K Buy
+8,082
New +$266K ﹤0.01% 313

Other funds holding OGN

Bartlett & Co's OGN Position: Q4 2023 in Review

Bartlett & Co reduced its Organon & Co (OGN) stake by 85% in Q4 2023, selling an estimated $25.3K and leaving 317 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Bartlett & Co first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $245K in Q2 2021. 718 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Bartlett & Co held 317 shares of Organon & Co worth $5K as of Q4 2023.
  • Bartlett & Co sold 1,863 Organon & Co shares in Q4 2023, an estimated $25.3K.
  • Organon & Co made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1076 holding.
  • Bartlett & Co first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
  • Bartlett & Co's Organon & Co position peaked at $245K in Q2 2021.
  • 718 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.